ZA9810186B - Imidazoylalkyl substituted with a five six or seven membered heterocyclic ring containing one nitrogen atom - Google Patents

Imidazoylalkyl substituted with a five six or seven membered heterocyclic ring containing one nitrogen atom

Info

Publication number
ZA9810186B
ZA9810186B ZA9810186A ZA9810186A ZA9810186B ZA 9810186 B ZA9810186 B ZA 9810186B ZA 9810186 A ZA9810186 A ZA 9810186A ZA 9810186 A ZA9810186 A ZA 9810186A ZA 9810186 B ZA9810186 B ZA 9810186B
Authority
ZA
South Africa
Prior art keywords
nitrogen atom
heterocyclic ring
membered heterocyclic
ring containing
imidazoylalkyl
Prior art date
Application number
ZA9810186A
Other languages
English (en)
Inventor
Wayne D Vaccaro
Daniel M Solomon
John J Piwinski
Ronald L Wolin
Robert G Aslanian
Stuart B Rosenblum
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA9810186B publication Critical patent/ZA9810186B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9810186A 1997-11-07 1998-11-06 Imidazoylalkyl substituted with a five six or seven membered heterocyclic ring containing one nitrogen atom ZA9810186B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96575497A 1997-11-07 1997-11-07

Publications (1)

Publication Number Publication Date
ZA9810186B true ZA9810186B (en) 1999-05-06

Family

ID=25510440

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810186A ZA9810186B (en) 1997-11-07 1998-11-06 Imidazoylalkyl substituted with a five six or seven membered heterocyclic ring containing one nitrogen atom

Country Status (12)

Country Link
EP (1) EP1028956A1 (fr)
JP (1) JP2001522845A (fr)
KR (1) KR20010031839A (fr)
CN (1) CN1285828A (fr)
AR (1) AR016671A1 (fr)
AU (1) AU1296799A (fr)
CA (1) CA2309609A1 (fr)
HU (1) HUP0102662A3 (fr)
IL (1) IL135727A0 (fr)
PE (1) PE130699A1 (fr)
WO (1) WO1999024421A1 (fr)
ZA (1) ZA9810186B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140337A (en) * 1997-12-23 2000-10-31 Schering Corporation Methods for the treatment of mental disorders
FR2827863A1 (fr) * 2001-07-27 2003-01-31 Sanofi Synthelabo Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique
US7183305B2 (en) 2003-11-11 2007-02-27 Allergan, Inc. Process for the synthesis of imidazoles
US7880017B2 (en) 2003-11-11 2011-02-01 Allergan, Inc. Process for the synthesis of imidazoles
WO2005058823A1 (fr) * 2003-12-17 2005-06-30 Takeda Pharmaceutical Company Limited Derives d'uree, processus de production correspondant et utilisation
US7598249B2 (en) * 2004-12-30 2009-10-06 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
WO2022175384A1 (fr) * 2021-02-17 2022-08-25 Fundación Universidad Católica De Valencia San Vicente Mártir Agents à petites molécules ayant une activité antivirale contre des virus à arn

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG44510A1 (en) * 1991-12-18 1997-12-19 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
CA2126086C (fr) * 1991-12-18 2000-03-28 Neng-Yang Shih Imidazoylalkyle substitue par un compose heterocyclique azote a six cycles
WO1995006037A1 (fr) * 1993-08-27 1995-03-02 Vrije Universiteit Nouveaux derives d'imidazoles a activite agoniste ou antagoniste du recepteur h3 a l'histamine
AR008293A1 (es) * 1996-08-16 1999-12-29 Schering Corp Composicion que comprende una cantidad antihistaminica para el tratamiento de las respuestas alergicas de las vias respiratorias superiores

Also Published As

Publication number Publication date
CN1285828A (zh) 2001-02-28
EP1028956A1 (fr) 2000-08-23
AR016671A1 (es) 2001-07-25
CA2309609A1 (fr) 1999-05-20
AU1296799A (en) 1999-05-31
IL135727A0 (en) 2001-05-20
KR20010031839A (ko) 2001-04-16
JP2001522845A (ja) 2001-11-20
WO1999024421A8 (fr) 1999-08-26
PE130699A1 (es) 1999-12-16
HUP0102662A3 (en) 2003-01-28
HUP0102662A2 (hu) 2001-12-28
WO1999024421A1 (fr) 1999-05-20

Similar Documents

Publication Publication Date Title
IL109145A0 (en) Heterocyclic compounds
GB9304500D0 (en) Heterocyclic compounds
GB9309716D0 (en) Heterocyclic derivatives
HU9401766D0 (en) Urea derivatives containing heterocyclic ring
IL109451A0 (en) Heterocyclic derivatives
ZA9810186B (en) Imidazoylalkyl substituted with a five six or seven membered heterocyclic ring containing one nitrogen atom
GB9314350D0 (en) Armide derivatives
HU9403465D0 (en) Heterocyclic derivatives
ZA948211B (en) Cyclic amine derivatives
IL111756A0 (en) Heterocyclic compounds
GB9317761D0 (en) Heterocyclic compounds
HU9402534D0 (en) New naphtoxazine derivatives
GB9319243D0 (en) Heterocyclic compounds
EP0783488A4 (fr) Composes heterocycliques a cinq elements
GB9320564D0 (en) Heterocyclic compounds
GB9419398D0 (en) Heterocyclic compounds
ZA943073B (en) Heterocyclic compounds
GB9325605D0 (en) Heterocyclic derivatives
GB9308065D0 (en) Heterocyclic derivatives
GB9308842D0 (en) Heterocyclic derivatives
GB9306453D0 (en) Heterocyclic derivatives
GB9316669D0 (en) Basic heterocyclic compounds
GB9304249D0 (en) New heterocyclic compounds
LTIP655A (en) New tetrahydonaphtalene derivatives
ZA942889B (en) New 3-dimethylaminoacridine derivatives